Obeticholic acid

BNF:
Not listed
Status:
Red
Decision Date:
May 2017
 

Comments

RED 1,2,3: NICE TA443 obeticholic acid is recommended for treating primary biliary cholangitis. (Decision date - May 2017)

Red Drug Classifications

  • 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
  • 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
  • 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app